Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative

Journal of Vascular Surgery

Volumn 63, Issue 1, 2016, Pages 182-189.e2

  De Martino, Randall R ^a   Beck, Adam W ^b   Hoel, Andrew W ^c   Hallett, John W ^d   Arya, Shipra ^e   Upchurch, Gilbert R ^f   Cronenwett, Jack L ^g   Goodney, Philip P ^g  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Roper Care Alliance   (United States)

^e EMORY UNIVERSITY   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY BYPASS; BLEEDING; BLOOD TRANSFUSION; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONFERENCE PAPER; ELECTIVE SURGERY; ENDOVASCULAR ANEURYSM REPAIR; FEMALE; GRAFT DYSFUNCTION; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SURGICAL RISK; ADVERSE EFFECTS; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL TRANSPLANTATION; CHI SQUARE DISTRIBUTION; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PROTECTION; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; ELECTIVE SURGICAL PROCEDURES; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROTECTIVE FACTORS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84955693040     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2015.08.058     Document Type: Conference Paper

References (22)

1. N.R. Hertzer, E.G. Beven, J.R. Young, P.J. O'Hara, W.F. Ruschhaupt 3rd, R.A. Graor, and et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management Ann Surg 199 1984 223 233
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
3. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin, and et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
4. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
5. R.R. De Martino, J. Eldrup-Jorgensen, B.W. Nolan, D.H. Stone, J. Adams, D.J. Bertges, and et al. Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery J Vasc Surg 59 2014 1615 1621 1621.e1
6. P.J. Devereaux, M. Mrkobrada, D.I. Sessler, K. Leslie, P. Alonso-Coello, A. Kurz, and et al. Aspirin in patients undergoing noncardiac surgery N Engl J Med 370 2014 1494 1503
7. O. Schouten, E. Boersma, S.E. Hoeks, R. Benner, H. van Urk, M.R. van Sambeek, and et al. Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 361 2009 980 989
8. J.L. Cronenwett, D.S. Likosky, M.T. Russell, J. Eldrup-Jorgensen, A.C. Stanley, and B.W. Nolan A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE) J Vasc Surg 46 2007 1093 1101 discussion: 1101-2
9. J.L. Cronenwett, L.W. Kraiss, and R.P. Cambria The Society for Vascular Surgery Vascular Quality Initiative J Vasc Surg 55 2012 1529 1537
10. T.G. Brott, J.L. Halperin, S. Abbara, J.M. Bacharach, J.D. Barr, R.L. Bush, and et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Circulation 124 2011 489 532
11. T.W. Rooke, A.T. Hirsch, S. Misra, A.N. Sidawy, J.A. Beckman, L.K. Findeiss, and et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery J Vasc Surg 54 2011 e32 58
12. M. Sobel, and R. Verhaeghe Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl 2008 815S 843S
13. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, L.T. Braun, M.A. Creager, B.A. Franklin, and et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 2011 2458 2473
14. J.P. Simons, D.T. Baril, P.P. Goodney, D.J. Bertges, W.P. Robinson, J.L. Cronenwett, and et al. The effect of postoperative myocardial ischemia on long-term survival after vascular surgery J Vasc Surg 58 2013 1600 1608
15. R.R. De Martino, B.W. Nolan, P.P. Goodney, C.K. Chang, A. Schanzer, R. Cambria, and et al. Outcomes of symptomatic abdominal aortic aneurysm repair J Vasc Surg 52 2010 5 12.e1
16. D.J. Bertges, P.P. Goodney, Y. Zhao, A. Schanzer, B.W. Nolan, D.S. Likosky, and et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients J Vasc Surg 52 2010 674 683 683.e1-3
17. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 Suppl 2 2014 S1 45
18. Antithrombotic Trialists Collaboration C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, and et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
19. T.M. Valentijn, S.E. Hoeks, E.J. Bakker, K.M. van de Luijtgaarden, H.J. Verhagen, R.J. Stolker, and et al. The impact of perioperative red blood cell transfusions on postoperative outcomes in vascular surgery patients Ann Vasc Surg 29 2015 511 519
20. F. Bursi, A. Barbieri, L. Politi, A. Di Girolamo, A. Malagoli, T. Grimaldi, and et al. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery Eur J Vasc Endovasc Surg 37 2009 311 318
21. M. Dunkelgrun, E. Boersma, O. Schouten, A.W. Koopman-van Gemert, F. van Poorten, J.J. Bax, and et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV) Ann Surg 249 2009 921 926
22. G.A. Antoniou, S. Hajibandeh, S. Hajibandeh, S.R. Vallabhaneni, J.A. Brennan, and F. Torella Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery J Vasc Surg 61 2015 519 532.e1